88167-50-4Relevant articles and documents
4-AMINOBUT-2-ENAMIDE DERIVATIVES AND SALTS THEREOF
-
Paragraph 0370, (2021/05/07)
The present invention provides an antitumor agent comprising a compound or a pharmaceutically acceptable salt thereof that covalently binds to GTP-bound KRASG12C as an active ingredient.
Synthesis of stable isotope labeled D9-Mabuterol, D9-Bambuterol, and D9-Cimbuterol
Tu, Yahui,Zhong, Jiaqi,Wang, Haoran,Pan, Jie,Xu, Zhongjie,Yang, Weicheng,Luo, Yong
, p. 546 - 551 (2016/11/23)
Three stable and simple synthetic routes of labeled D9-Mabuterol, D9-Bambuterol, and D9-Cimbuterol were described with 98.5%, 99.7%, and 98.4% isotopic abundance and good purity. These structures and isotope-abundance were confirmed according to 1H NMR and liquid chromatography-tandem mass spectrometry.
NOVEL PHENYLETHANOLAMINE COMPOUNDS HAVING BETA2-ACCEPTOR EXCITATORY FUNCTION AND THEIR PREPARATION METHOD
-
Page 5, (2010/02/07)
The invention provides compounds of formula ( I ) and pharmaceutically acceptable salts thereof, wherein R1 is H, chlorine, or bromine; R2 is electron attractive groups selected from the group consisting of CF3, CN, fluori